Ikarovec
Biotechnology Research
Norwich, Norfolk, United Kingdom
8 employees
- Employees
- 8
- Contacts
- 3
- Emails
- 3
Ikarovec Overview
- Headquarters
- Norwich, Norfolk, United Kingdom
- Website
- www.ikarovec.com
- Industry
- Biotechnology Research
- Employees
- 8
- Founded
- 2018
- Funding
- 10.3M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Ikarovec
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
Ikarovec Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Ikarovec Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Laura Vaux, Phd | Director of Preclinical Studies at Ikarovec |
View
|
|
| Katie Binley | Chief Scientific Officer at Ikarovec Limited | Greater Oxford Area, United Kingdom |
Email
|
| Thomas Ciulla, Md, Mba | President and CEO, Ikarovec | Waltham, Massachusetts, United States |
Email
|
| Jean-Philippe Combal | Paris, ÎLe-de-france, France |
Email
|
Employees by Management Level
Executive
2 profiles
Director
1 profile
Compare Similar Companies to Ikarovec
Be Biopharma
Biotechnology
AvenCell
Biotechnology
Antiverse
Biotechnology Research
Shift Bioscience
Biotechnology Research
Theriva Biologics, Inc.
Biotechnology Research
GENE VECTOR
Biotechnology Research
Fuse Vectors
Biotechnology Research
GlyProVac
Biotechnology Research
Serendip innovations
Biotechnology Research
ATLyphe AG
Biotechnology Research